Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever’s Failed Bid Puts Pressure On GSK Spin-Out Plans

Bid Saw UK Pharma Major’s Shares Rise

Executive Summary

GSK now looks free to pursue its ‘Plan A’ for the consumer division, but activist investors may push for a new bidder to be found.

You may also be interested in...



Ipsen To Exit Consumer Health And Focus On Specialty Pharma

The French group is sharpening its focus on specialty care  in oncology, rare disease and neuroscience, so is looking to divest its consumer health division to Mayoly Spindler.

Xevudy Helps GSK Ride Out Depressed Shingrix Sales

GlaxoSmithKline is preparing for the long-awaited spin-out of its consumer division later this year but needs to see Shingrix bounce back from its pandemic blues to help the company reignite growth.

With Investor Support Thin On The Ground, Unilever Won't Up Bid For GSK Consumer Healthcare

Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC145746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel